Zacks Investment Management Emergent Bio Solutions Inc. Transaction History

Zacks Investment Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$48.23 - $66.16 $970,049 - $1.33 Million	-20,113 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$55.63 - $73.24 $48,453 - $63,792	-871 Reduced 4.15%	20,113 $1.19 Million
Q3 2018 Nov 14, 2018	BUY	$52.05 - $66.51 $6,974 - $8,912	134 Added 0.64%	20,984 $1.38 Million
Q2 2018 Aug 14, 2018	BUY	$48.33 - $55.64 $20,153 - $23,201	417 Added 2.04%	20,850 $1.05 Million
Q1 2018 May 14, 2018	BUY	$44.44 - $54.39 $66,126 - $80,932	1,488 Added 7.85%	20,433 $1.08 Million
Q4 2017 Feb 14, 2018	BUY	$37.77 - $47.75 $715,552 - $904,623	18,945	18,945 $880,000

158

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $561M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.